Sinovac Biotech from China seeks co-financing for COVID-19 vaccine trial in Bangladesh


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ chinese-vaccine-company-sinovac-biotech-seeks-cofinancing-covid19-vaccine-trial-in-bangladesh
The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine

The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine.

The company was given permission to carry out the phase-3 human trial about a month back by the government.

Responding to an unconfirmed report about the Chinese company asking for co-financing for a vaccine trial, the Health Division Secretary of the government of Bangladesh Abdul Mannan confirmed to the official news agency BSS yesterday that Sinovac Biotech Ltd has sent a letter to the government seeking co-financing for COVID 19 vaccine trial.

He said that the company had not asked for co-financing by the Bangladesh government when it obtained the approval to carry out the trial.

The Chinese company had originally put up the proposal to Bangladesh through the Dhaka based International Centre for Diarrheal Disease Research, Bangladesh (ICDDR’B). The government granted final clearance for the clinical trial on August 27.

An official of the ICDDR’B told BSS that it is now entirely up to the government to decide if they will agree to the co-financing proposal as there was no mention of it in the original proposal of the Chinese company.

Under the agreement before the co-financing was sought, Bangladesh would have got one lakh vaccines for free. It would also have got priority to purchase adequate quantum of vaccines from the Chinese company Sinovac Biotech.

Meanwhile, Bangladesh Govt has issued directives restricting certain activities in view of the security, law and order and COVID-19 pandemic during the upcoming Durga Puja in the country. The directives came after the meeting Chaired by Home Minister Asaduzzamn Khan on Sunday in Dhaka.

The meeting requested the leaders of the nationwide Sarbajanin Puja Committee to limit the number of Puja mandaps as much as possible. The government has also decided that no procession will be allowed during the immersion of the idol at the end of the Durga Puja, said the press release issued by the Home Ministry.

The meeting decided that the Puja Celebration Committee will take steps to reduce the number of public gatherings at the Puja Mandap and to broadcast the Anjali program live. The organisers have been asked to maintain health guidelines such as social distancing, wearing of masks and using the hand sanitiser for people visiting the mandaps.

Police forces will be on mobile duty to deal with law and order situations. The guidelines also require that various ceremonies should be held maintaining religious harmony. The Puja Udjapan Committee will be coordinating with the local administration and law enforcement agencies for the management of the mandaps.

Tags : #SinivacBiotech #China #Bangladesh #COVID-19Vaccine #Phase-3Trial #LatestPharmaNews5thOct #LatestCOVIDNews5thOct

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026